Alphamab Oncology Market Cap

Alphamab Oncology has a market cap or net worth of 6.53 billion as of June 20, 2025. Its market cap has increased by 40.78% in one year.

Market Cap

6.53B

Enterprise Value

5.06B

Revenue

681.16M

Ranking

n/a

PE Ratio

37.53

Stock Price

6.79

Market Cap Chart

Since December 12, 2019, Alphamab Oncology's market cap has decreased from 12.11B to 6.53B, a decrease of -46.05%. That is a compound annual growth rate of -10.57%.

Market Cap History

Date	Market Cap	% Change
Jun 19, 2025	6.67B	97.96%
Dec 31, 2024	3.37B	-47.42%
Dec 29, 2023	6.41B	-36.87%
Dec 30, 2022	10.15B	-20.36%
Dec 31, 2021	12.74B	-16.28%
Dec 31, 2020	15.22B	21.20%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines	254.16B
Hansoh Pharmaceutical Group Company	168.27B
JD Health International	134.72B
Innovent Biologics	127.34B
WuXi Biologics	104.57B
CSPC Pharmaceutical Group	93.60B
Sino Biopharmaceutical	89.42B
Akeso	84.42B

Market Cap Rankings